Although the N-terminal region in human apolipoprotein (apo) A-I is thought to stabilize the lipid-free structure of the protein, its role in lipid binding is unknown. Using synthetic fragment peptides, we examined the lipid-binding properties of the first 43 residues (1-43) of apoA-I in comparison with residues 44-65 and 220-241, which have strong lipid affinity in the molecule. Circular dichroism measurements demonstrated that peptides corresponding to each segment have potential propensity to form alpha-helical structure in trifluoroethanol. Spectroscopic and thermodynamic measurements revealed that apoA-I (1-43) peptide has the strong ability to bind to lipid vesicles and to form alpha-helical structure comparable to apoA-I (220-241) peptide. Substitution of Tyr-18 located at the center of the most hydrophobic region in residues 1-43 with a helix-breaking proline resulted in the impaired lipid binding, indicating that the alpha-helical structure in this region is required to trigger the lipid binding. In contrast, apoA-I (44-65) peptide exhibited a lower propensity to form alpha-helical structure upon binding to lipid, and apoA-I (44-65/S55P) peptide exhibited diminished, but not completely impaired, lipid binding, suggesting that the central region of residues 44-65 is not pivotally involved in the formation of the alpha-helical structure and lipid binding. These results indicate that the most N-terminal region of apoA-I molecule, residues 1-43, contributes to the lipid interaction of apoA-I through the hydrophobic helical residues.
Human apolipoprotein (apo) A-I, a 243 amino acid protein, is the major protein component of high-density lipoprotein (HDL). ApoA-I plays an important role in lipoprotein metabolism, reverse cholesterol transport pathway, and protection against the development of atherosclerosis.1) In reverse cholesterol transport pathway, lipid-free or lipid-poor apoA-I molecules remove cholesterol from peripheral cells and transport it in the form of HDL back to the liver for excretion.2) Lipid-free apoA-I is folded into two domains, comprising an N-terminal domain forming a four-helix bundle and a discrete C-terminal domain, which is predominantly involved in lipid-protein interactions. These interactions are critical for HDL generation, including initial lipid binding and cholesterol efflux from plasma membrane.3) ApoA-I Nichinan, a naturally occurring human apoA-I variant with a deletion of E235 located in the C-terminus, is associated with low HDL cholesterolemia probably due to the impaired lipid binding and cellular interactions. 4,5) Computational analysis of the amino acid sequence of human apoA-I reveals that residues 44-243, encoded by exon 4, is composed of 11-or 22-amino acid tandem repeats, which can form amphipathic a-helices mostly punctuated by proline residues. 6) Studies of synthetic peptides corresponding to each of 22-residue amphipathic segments of apoA-I have shown that the last repeated helix (residues 220-241) has greatest lipid affinity. 7,8) In addition, our previous studies using deletion mutants of apoA-I demonstrated that deletion in the last helix leads to significant decreases in lipid-binding affinity compared to intact apoA-I. 9,10) A lack of E235 in apoA-I Nichinan variant is considered to bring about at least two possible structural influences such as 1) a negative charge ablation and 2) disturbance of amino acid distribution on the helix cross-section (i.e., loss of amphipathicity) (Fig. 1). Previously, Panagotopulos et al. have revealed that the E235K mutation in full-length apoA-I does not affect lipid microsolubilization and cellular cholesterol efflux, 11) suggesting the possibility that amphipathic nature of the C-terminal region in apoA-I Nichinan is influenced by the disturbance of amino acid distribution caused by E235 deletion. To examine the influences of E235 deletion on the a-helical structure and lipid interaction of the C-terminal region in apoA-I, we used a series of variant peptides corresponding to residues 220-241 of the apoA-I molecule in addition of DE235: E235A in which E235 was substituted with nonpolar alanine residue to examine the influence of a negative charge ablation, and L230P in which L230 was substituted with proline residue to disrupt the putative a-helical structure. We previously demonstrated that proline insertion instead of leucine residue at position 230 disrupts the C-ter- The C-terminal domain of apolipoprotein (apo) A-I plays an important role in lipid binding. ApoA-I Nichinan, a naturally occurring human apoA-I variant with a deletion of E235 located i...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.